Literature DB >> 9457003

Collecting saliva samples by mail.

J F Etter1, T V Perneger, A Ronchi.   

Abstract

Collecting saliva samples by mail can serve numerous purposes in epidemiologic research. The objectives of this study were to assess what proportion of participants in a mail survey would provide a saliva sample and whether incentives could improve participation. In 1995, 2,994 students, faculty, and staff members of Geneva University, Geneva, Switzerland, were randomized to receive, together with a mailed questionnaire about smoking, a saliva vial, a ballpoint pen, the offer of a lottery, or any combination of these. After one mailing and a reminder letter, response rates were 52% among those who had been requested to provide saliva and 63% among controls (p < 0.001). In the former group, most respondents (98%) provided a saliva sample. Incentives improved participation only among those who were asked to provide saliva (lottery: +11% response, p = 0.003; pen: +6% response, p = 0.1). The final participation, after up to three reminders, was 76% overall. The authors conclude that while the collection of saliva samples by mail is feasible it tends to decrease response rates.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9457003     DOI: 10.1093/oxfordjournals.aje.a009426

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  16 in total

1.  Short-term impact of a university based smoke free campaign.

Authors:  J F Etter; A Ronchi; T Perneger
Journal:  J Epidemiol Community Health       Date:  1999-11       Impact factor: 3.710

2.  Genetic research participation in a young adult community sample.

Authors:  Carla L Storr; Flora Or; William W Eaton; Nicholas Ialongo
Journal:  J Community Genet       Date:  2014-06-20

3.  Collecting saliva by mail for genetic and cotinine analyses in participants recruited through the Internet.

Authors:  Jean-François Etter; Elisabeth Neidhart; Sonia Bertrand; Alain Malafosse; Daniel Bertrand
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

4.  Measurement of self reported active exposure to cigarette smoke.

Authors:  J F Etter; T V Perneger
Journal:  J Epidemiol Community Health       Date:  2001-09       Impact factor: 3.710

5.  ITC "spit and butts" pilot study: the feasibility of collecting saliva and cigarette butt samples from smokers to evaluate policy.

Authors:  Brian V Fix; Richard O'Connor; David Hammond; Bill King; Ann McNeill; James Thrasher; Marcelo Boado; K Michael Cummings; Hua-Hie Yong; Mary E Thompson; Andrew Hyland
Journal:  Nicotine Tob Res       Date:  2010-01-15       Impact factor: 4.244

6.  A content analysis of attributions for resuming smoking or maintaining abstinence in the post-partum period.

Authors:  John B Correa; Vani N Simmons; Steven K Sutton; Lauren R Meltzer; Thomas H Brandon
Journal:  Matern Child Health J       Date:  2015-03

7.  The role of smoking and gingival crevicular fluid markers on coronally advanced flap outcomes.

Authors:  Başak Kaval; Diane E Renaud; David A Scott; Nurcan Buduneli
Journal:  J Periodontol       Date:  2013-05-31       Impact factor: 6.993

8.  Randomized controlled trial of mailed Nicotine Replacement Therapy to Canadian smokers: study protocol.

Authors:  John A Cunningham; Scott T Leatherdale; Peter L Selby; Rachel F Tyndale; Laurie Zawertailo; Vladyslav Kushnir
Journal:  BMC Public Health       Date:  2011-09-28       Impact factor: 3.295

Review 9.  Methods to increase response to postal and electronic questionnaires.

Authors:  Philip James Edwards; Ian Roberts; Mike J Clarke; Carolyn Diguiseppi; Reinhard Wentz; Irene Kwan; Rachel Cooper; Lambert M Felix; Sarah Pratap
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

10.  Evaluating the effectiveness of using personal tailored risk information and taster sessions to increase the uptake of smoking cessation services: study protocol for a randomised controlled trial.

Authors:  Hazel Gilbert; Stephen Sutton; Richard Morris; Steve Parrot; Simon Galton; Irwin Nazareth
Journal:  Trials       Date:  2012-10-18       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.